Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Six Korean Cities Compete To Host Government Brain Research Center

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's six big provincial cities, including Incheon near Seoul, are competing to win a huge contract that will cover the opening of the country's first government-sponsored brain research institute, which is likely to be surrounded by pharmaceutical, biologics and medical device companies

You may also be interested in...



Two Leading Korean Universities Move To Open Pharmacy Colleges To Meet Growing Demand For Pharma/Biotech Services

SEOUL - Sparked by the South Korean government's push to strengthen the local pharmaceutical industry, the country's two most prestigious private universities are now revealing their plans to open their own pharmacy schools in addition to their currently existing medical schools

Two Leading Korean Universities Move To Open Pharmacy Colleges To Meet Growing Demand For Pharma/Biotech Services

SEOUL - Sparked by the South Korean government's push to strengthen the local pharmaceutical industry, the country's two most prestigious private universities are now revealing their plans to open their own pharmacy schools in addition to their currently existing medical schools

Korean Celltrion Signs Letter Of Intent With U.S. CDC To Develop Rabies Agents

SEOUL - South Korean biopharmaceutical manufacturing company Celltrion signed a letter of intent Jan. 29 with the U.S. Centers for Disease Control to cooperate in the development and production of antibody drugs to fight rabies, a company official said Thursday

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071321

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel